baber/WOPTO huggingface dataset:
Patent AU-2019342135-A1 (AU)
Title: Channel state information reference signal
Inventor: CHO CHOONG WON
IPC: H04B7/0417
Filed: 2019-09-19
Abstract: In a Multiple-Input Multiple-Output (MIMO) system including a large number of antenna ports, a base station such as a Node B communicates a total number of antenna ports by communicating the number of antenna ports per Channel State Information Reference Signal (CSI-RS) configuration and one or more CSI-RS configurations. A User Equipment determines the number of antenna ports from the information communicated by the base station by determining the number of CSI-RS configurations sent by the base station and multiplying that number by the number of antenna ports per CSI-RS configuration indicated by the base station.
Patent AU-2019374439-A1 (AU)
Title: Method of treatment of a surface
Inventor: KOTSAKIS PANAGIOTIS
IPC: C09D5/14
Filed: 2019-11-05
Abstract: A method of treatment of a marine surface to improve the resistance of the surface to fouling from a marine organism, the method comprising treatment of a surface prone to fouling from a marine organism with a composition comprising a lactam, wherein the composition comprises from 0.0005 to 5 wt.% of a lactam; wherein the surface to be treated is selected from steel, light alloy, plastic or composites; and, wherein the marine organism is
Patent AU-2019385665-A1 (AU)
Title: Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant MVA encoding 4-1BBL (CD137L) and/or CD40l
Inventor: LAUTERBACH HENNING
IPC: A61K39/00
Filed: 2019-11-20
Abstract: The invention relates to a composition and related methods for reducing tumor volume and/or increasing the survival of a cancer patient. The composition comprises a recombinant MVA encoding a Tumor Associated Antigen ("TAA") as well as 4-1BBL and/or CD40L and can be administered to a subject in any suitable manner, including by intravenous and/or intratumoral administration.
Patent AU-2019405587-A1 (AU)
Title: Agent containing 4-phenylbutyrate, for preventing or treating presbyopia
Inventor: KATO MASATOMO
IPC: A61K9/06
Filed: 2019-12-17
Abstract: The present disclosure provides an agent that is for preventing or treating eye diseases such as presbyopia and that contains, as an active ingredient, 4-phenylbutyrate or an ester thereof, or a pharmaceutically acceptable salt thereof.
Patent AU-2019408336-A1 (AU)
Title: Phenylpyrrolidine compound and use thereof
Inventor: ZHANG XUEJUN
IPC: C07D401/14
Filed: 2019-12-17
Abstract: The present invention provides a compound. The compound is a compound as represented by formula (A) or a tautomer, a stereisomer, a hydrate, a solvate, a salt or a prodrug of the compound as represented by formula (A). R is R
Patent AU-2020200379-A1 (AU)
Title: Delivery across cell plasma membranes
Inventor: MAGUIRE MICHAEL
IPC: C12N15/85
Filed: 2020-01-20
Abstract: Delivering a payload across a plasma membrane of a cell includes providing a population of cells and contacting the population of cells with a volume of an aqueous solution. The aqueous solution includes the payload and alcohol content greater than 5 percent 5 concentration. The volume of the aqueous solution may be a function of exposed surface area of the population of cells, or may be a function of a number of cells in the population of cells. Related compositions, apparatus, systems, techniques, and articles are also described.
Patent AU-2020202920-A1 (AU)
Title: Wheel rack assembly
Inventor: NORTHEY TIM
IPC: B60R9/048
Filed: 2020-05-01
Abstract: A wheel rack assembly comprises support structure, a lever, and biasing means. The support 
structure arranged to at least partly support a wheel. The lever pivotally mounted relative to 
the support structure so that the lever can pivot about a pivot relative to the support structure 
in a wheel-engaging direction and a wheel-releasing direction; and biasing means arranged to 
resiliently bias the lever in at least the wheel-engaging direction to releasably clamp or fasten 
a wheel relative to the support structure.  
[Figure 2].
1/5 
Len 
000 
00 
to 
LO 
r4 r~kf ~tf to 
LO ie 
II N 
:1L 
00 
-1-
Patent AU-2020207174-A1 (AU)
Title: Seagoing vessel clean sailing method and vessel
Inventor: PENG SIGAN
IPC: B01D53/78
Filed: 2020-01-06
Abstract: The present invention relates to a seagoing vessel clean sailing method, comprising the steps of: (a) washing engine exhaust gas by means of seawater and producing washed seawater; (b) performing an open-type washing seawater treatment, comprising: performing an open-type neutralization treatment on the washed seawater; and/or (c) performing a closed-type washing seawater treatment, comprising: (i) storing the washed seawater into a reservoir, and (ii) performing a closed-type neutralization treatment on the washed seawater. The present invention further relates to a vessel. The present invention is used for marine vessels to maintain the unique advantages of both economy and environmental protection under the premise of ensuring the safety of navigation, so as to fulfil the global vessel sulphur-limiting regulation of the United Nations.
Patent AU-2020210909-A1 (AU)
Title: Compositions for treating citrus disease and promoting yield increase in row crops
Inventor: THOMPSON BRIAN
IPC: A01N37/46
Filed: 2020-01-22
Abstract: Isolated bioactive priming peptides and bioactive priming compostions comprising bioactive priming polypeptides and/or inducer compounds are provided that are useful when applied to plants in agricultural formulations. Methods of using the isolated bioactive priming peptides and/or compositions are also provided which are applied exogenously to the surface of a plant or a plant cell membrane or endogenously to the interior of a plant or to a plant cell.
Patent AU-2020250241-A1 (AU)
Title: System and method for food waste decomposition
Inventor: HOEN JASON
IPC: B02C23/24
Filed: 2020-10-08
Abstract: Machines, processes and methods in relation to processing of waste, in particular food waste 
or organic waste are provided. Some embodiments of described machines, processes and 
methods include a drum to receive waste, mixing blades to process waste, a source of air that 
is rich in reactive oxygen species, an air flow system comprising a heater to circulate air 
through the drum, and sensors provided in the machine to monitor operating parameters. A 
control system is configured to control operation of the machine.
3 of 62 
00 
Cd.) 
00C 
.2 m aj 
a) a 
> a a 
c rn 
0 j E 
0~0 
a))
Patent AU-2020250269-A1 (AU)
Title: Bricks, block, and pavers
Inventor: THURLOW PHIL
IPC: E04C1/42
Filed: 2020-10-08
Abstract: C:\Users \g\AppDaa\Roa ing\iManagc\Work\Recent\35548961AU Bricks block andpa rs\Disioal spciicaon - Brcksblocks paers(20745378.I).doc-8 10/2020 
ABSTRACT 
A brick, block, or paver including an aggregate of recycled glass, at least one face having a 
surface treatment to expose the glass. The aggregate of recycled glass has a particle size 
distribution with particle sizes varying up to approximately 7mm. In a preferred 
embodiment the product consists of aggregate mixed with cement, the recycled glass 
aggregate forming between 10% and 100% of the overall aggregate in the mix.
Patent AU-2020256242-A1 (AU)
Title: Process for producing 1,1,1,4,4,4-hexafluorobut-2-ene
Inventor: PENG SHENG
IPC: C07C19/10
Filed: 2020-04-03
Abstract: A process for producing
Patent AU-2020256362-A1 (AU)
Title: Fire fighting training system with steam/smoke generation
Inventor: BLACKBURN JOHN JOSEPH
IPC: G09B19/00
Filed: 2020-10-14
Abstract: A firefighting training system including a display device configured to display an 
actual or simulated fire and a sensor configured to detect an actual, simulated or virtual 
extinguishant that is directed at the display device. The system further includes a smoke or 
steam generation system configured to provide an output and a controller operatively 
coupled to the display device, the sensor and the generation system. The controller is 
configured to control the display of the actual or simulated fire and the output based at least 
in part upon an output of the sensor.
Patent AU-2020273317-A1 (AU)
Title: Wearable surgical assembly
Inventor: SCLAFANI ADAM C
IPC: A62B18/04
Filed: 2020-11-19
Abstract: There is disclosed a wearable surgical assembly configured to be removably coupled to a 
surgical helmet comprising a static tab and a face frame, said surgical assembly comprising: 
a surgical garment configured to provide a sterile barrier between a medical environment 
and a wearer, said surgical garment defining an environment side and a wearer side, said 
surgical garment comprising a material defining an opening; a transparent face shield 
disposed within said opening of said material and configured to define a portion of said 
surgical garment, said transparent face shield comprising a top, a bottom, and an axis that 
extends from top-to-bottom; a tab defining a first opening; said transparent face shield 
defines a second opening and a third opening positioned on opposing sides of said axis of 
said transparent face shield; and wherein said first opening is configured to receive the static 
tab of the surgical helmet to removably couple said wearable surgical assembly to the 
surgical helmet.  
20903112.1:DCC
1/47 
12 
16 
10 
...........
Patent AU-2020290414-A1 (AU)
Title: Methods and formulations for treating vision disorders
Inventor: WOODWARD DAVID F
IPC: A61K31/137
Filed: 2020-06-09
Abstract: Ocular formulations comprising long-acting β-adrenoceptor agonist (LABA) compounds, long-acting muscarinic antagonists (LAMA), and combinations thereof are provided. Methods for treating vision disorders,, with LABAs, LAMAs, and combinations thereof are also provided.
Patent AU-2020291776-A1 (AU)
Title: Packet loss concealment for dirac based spatial audio coding
Inventor: FUCHS GUILLAUME
IPC: G10L19/005
Filed: 2020-06-05
Abstract: A method for loss concealment of spatial audio parameters, the spatial audio parameters comprise at least a direction of arrival information; the method comprising the following steps: receiving a first set of spatial audio parameters comprising at least a first direction of arrival information; receiving a second set of spatial audio parameters, comprising at least a second direction of arrival information; and replacing the second direction of arrival information of a second set by a replacement direction of arrival information derived from the first direction of arrival information, if at least the second direction of arrival information or a portion of the second direction of arrival information is lost or damaged. To improve the concealment of lost or damaged direction of arrival, the replacement direction of arrival may additionally be dithered and/or extrapolated depending on a level of diffuseness.
Patent AU-2020295807-A1 (AU)
Title: Lipid nanoparticle or liposome delivery of hepatitis B virus (HBV) vaccines
Inventor: HORTON HELEN
IPC: A61K39/12
Filed: 2020-06-19
Abstract: Pharmaceutical compositions containing hepatitis B virus (HBV) vaccines and lipids are described. Methods of inducing an immune response against HBV or treating an HBV-induced disease, particularly in individuals having chronic HBV infection, using the disclosed pharmaceutical compositions are also described.
Patent AU-2020296895-A1 (AU)
Title: Systems and methods for user verification based on actigraphy data
Inventor: DORN JONAS
IPC: G16H40/67
Filed: 2020-06-16
Abstract: The invention provides systems and methods for providing a user-specific activity model based on actigraphy data and for user verification based on a user-specific activity model based on actigraphy data.
Patent AU-2020323825-A1 (AU)
Title: Kit for predicting or diagnosing nonalcoholic fatty liver disease, and method for diagnosing nonalcoholic fatty liver disease
Inventor: KO GWANG PYO
IPC: G01N33/569
Filed: 2020-07-30
Abstract: The present invention relates, with respect to nonalcoholic fatty liver disease, to a kit for predicting or diagnosing the risk of the disease, a method for providing information for predicting or diagnosing the risk of the disease, a method for screening a therapeutic agent for the disease, and a pharmaceutical composition for prevention or treatment of the disease. Specifically, the present invention can effectively predict or diagnose the risk of nonalcoholic fatty liver disease and, in particular, has superior significance in prediction and information provision for non-obese subjects. Accordingly, the present invention can be effectively used in the prevention or treatment of the disease by providing effective information on nonalcoholic fatty liver disease. In addition, the pharmaceutical composition for prevention or treatment can be effectively used in the treatment of nonalcoholic fatty liver disease.
Patent AU-2020330542-A1 (AU)
Title: Articles and methods for administration of therapeutic agents
Inventor: TRAVERSO CARLO GIOVANNI
IPC: A61K31/375
Filed: 2020-08-12
Abstract: Articles and methods for delivering a therapeutic agent to a subject are described. These articles and methods may be useful, in some cases, for the delivery of therapeutic agents to the colon of a subject. In some embodiments, an article is configured to release a secretion inducing agent e.g., to stimulate the release of intestinal fluids. The article, in some embodiments, comprises a therapeutic agent such that the stimulated release of intestinal fluid increases the amount of therapeutic agent available for absorption by the colon. For example, in some embodiments, the articles and methods described herein advantageously promote increased absorption of therapeutic agents in subjects as compared to traditionally administered therapeutic agents without additional components such as a secretion inducing agent. In some embodiments, articles and methods described herein may increase the motility of the colon of a subject. The increase in contractions and movement of fluidic in the colon caused by increase motility may advantageously facilitate the dissolution or absorption of the therapeutic agent.
Patent AU-2020362341-A1 (AU)
Title: Heteroaryl-substituted pyrazine derivatives as pesticides
Inventor: TURBERG ANDREAS
IPC: A01N43/78
Filed: 2020-10-08
Abstract: The present invention relates to novel heteroaryl-substituted pyrazine derivatives of the general formula (I), in which the structural elements R
Patent AU-2020377984-A1 (AU)
Title: Techniques and associated systems and methods for determining train motion characteristics
Inventor: SENNA JOSHUA
IPC: B61L15/00
Filed: 2020-11-05
Abstract: Described herein are techniques for determining motion characteristics (
Patent AU-2020378661-A1 (AU)
Title: Transpedicular anchoring screw with reinforced secondary stability
Inventor: GRAZIANI NOËL
IPC: A61B17/70
Filed: 2020-11-05
Abstract: A transpedicular anchoring screw (1) comprising a screw body (11) having a first helical thread (2) having: - a proximal part (22) having notched portions inscribed in notched angular sectors and separated by separation portions inscribed in angular separation sectors, where, on a screw pitch, a ratio between the sum of the measurements of the angular separation sectors and the sum of the measurements of the notched angular sectors is between 50% and 150%; and - a distal part (23) having notched portions inscribed in notched angular sectors and separated by distal separation portions inscribed in angular separation sectors, where, on a screw pitch, a ratio between the sum of the measurements of the angular separation sectors and the sum of the measurements of the notched angular sectors is between 0% and 10%.
Patent AU-2020387380-A1 (AU)
Title: TREM2 antibodies and uses thereof
Inventor: ANDREWS FOREST HOYT
IPC: C07K16/28
Filed: 2020-11-16
Abstract: The present invention relates to TREM2 antibodies, and uses thereof, for treating diseases such as neurodegenerative diseases.
Patent AU-2020393170-A1 (AU)
Title: System and method for delivery of gas to a tissue
Inventor: CONFINO HILA
IPC: A61K33/00
Filed: 2020-11-25
Abstract: A system for delivery of gas to a tissue, comprises: a first container containing the gas, an applicator having a distal end arranged to deliver the gas to the tissue, a second container containing a purging gas, and; and a flow control system for controlling flow of gas. The system also comprises a three-port valve having a first port for receiving the gas from the first container, a second port for receiving the purging gas from the second container, and a third port in fluid communication with the applicator. The valve is switchable between a first state at which the first port fluidly connects to the third port, and a second state at which the second port fluidly connects to the third port.
Patent AU-2020397955-A1 (AU)
Title: Managing fluid levels in a patient and associated devices, systems, and methods
Inventor: LEVIN HOWARD R
IPC: A61M5/14
Filed: 2020-12-04
Abstract: Devices, systems, and methods for delivering fluid therapy to a patient are disclosed herein. An exemplary method can comprise obtaining a urine output rate from a patient; causing a diuretic to be provided to the patient at a dosage rate, wherein the dosage rate is increased over a period of time such that the urine output rate increases to be above a predetermined threshold within the period of time; and causing a hydration fluid to be provided to the patient at a hydration rate. The hydration rate can be set based on the urine output rate to drive net fluid loss from the patient.
Patent AU-2020403852-A1 (AU)
Title: Implant component
Inventor: DALLA PRIA PAOLO
IPC: A61F2/40
Filed: 2020-12-15
Abstract: A humeral implant component (1, 28) connectable to another humeral implant component (2), the humeral implant component (1, 28) comprising: a longitudinal axis (L), a first end (3) and a second end (4), the first end (3) and the second end (4) opposing each other along the longitudinal axis (L) of the humeral implant component (1, 28), and an interface part (5a, 5b) for connecting the humeral implant component (1, 28) to the other humeral implant component (2), wherein the interface part (5a, 5b) is tapered along the longitudinal axis (L) in a direction from the second end (4) to the first end (3), the interface part (5a, 5b) being engageable with a tapered interface part (6) of the other humeral implant component (2) to form a tapered connection between the humeral implant component (1, 28) and the other humeral implant component (2), wherein the humeral implant component (1, 28) further comprises a through hole (7) extending along the longitudinal axis (L) for locking the tapered connection by a longitudinal fastener (8).
Patent AU-2020416878-A1 (AU)
Title: Map generation method and apparatus, electronic device, and computer storage medium
Inventor: LI JIANQUAN
IPC: A63F13/60
Filed: 2020-10-29
Abstract: A map generation method and apparatus, an electronic device and a computer storage medium. Said method comprises: selecting a plurality of sub-level maps from a sub-level map library; sequentially placing, within a predetermined map area, first M sub-level maps among the plurality of sub-level maps, all the first M sub-level maps being located within the map area, and the first M sub-level maps not overlapping with each other; and sequentially placing the remaining sub-level maps such that the remaining sub-level maps do not overlap with the sub-level maps having placed within the map area, and being in connectivity with at least one sub-level map among the sub-level maps having placed within the map area, so as to obtain a target map.
Patent AU-2020466345-A1 (AU)
Title: User mediation for hotword/keyword detection
Inventor: KRACUN ALEKS
IPC: G10L15/065
Filed: 2020-12-15
Abstract: Techniques are described herein for improving performance of machine learning model(s) and thresholds utilized in determining whether automated assistant function(s) are to be initiated. A method includes: receiving, via one or more microphones of a client device, audio data that captures a spoken utterance of a user; processing the audio data using a machine learning model to generate a predicted output that indicates a probability of one or more hotwords being present in the audio data; determining that the predicted output satisfies a secondary threshold that is less indicative of the one or more hotwords being present in the audio data than is a primary threshold; in response to determining that the predicted output satisfies the secondary threshold, prompting the user to indicate whether or not the spoken utterance includes a hotword; receiving, from the user, a response to the prompting; and adjusting the primary threshold based on the response.
Patent AU-2021200228-A1 (AU)
Title: Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same
Inventor: MCWHIRTER JOHN
IPC: C07K16/28
Filed: 2021-01-15
Abstract: A genetically modified non-human animal is provided, wherein the non-human 
animal expresses an antibody repertoire capable of pH dependent binding to 
antigens upon immunization. A genetically modified non-human animal is provided 
that expresses human immunoglobulin light chain variable domains derived from a 
limited repertoire of human immunoglobulin light chain variable gene segments that 
comprise histidine modifications in their germline sequence. Methods of making non
human animals that express antibodies comprising histidine residues encoded by 
histidine codons introduced into immunoglobulin light chain nucleotide sequences 
are provided.
Patent AU-2021200422-A1 (AU)
Title: Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists
Inventor: DIEHL LAURI
IPC: G01N33/53
Filed: 2021-01-22
Abstract: Methods of assessing or monitoring the effect, efficacy, responsiveness to treatment, 
and/or determining a dose or dosing regimen of therapeutic agents, such as integrin beta7 
antagonists, for the treatment of gastrointestinal inflammatory disorders are provided. In 
certain aspects, methods of using integrin beta7 subunit-containing receptor occupancy by the 
integrin beta7 antagonist on colonic lymphocytes as an indicator ("biomarker") of the effect, 
efficacy, or responsiveness to treatment, and/or as a means to determine dosing or dosing 
regimens of therapeutic agents such as beta7 integrin antagonists for the treatment of 
gastrointestinal inflammatory disorders are provided. In certain aspects, methods of assessing 
the effect, efficacy, or responsiveness to beta7 integrin antagonist treatment by measuring 
gene expression levels of one or more integrin receptor ligands, lymphocyte genes, cytokine 
genes, or the number of alphaE-positive cells in intestinal crypt epithelium are provided.  
17350754_1 (GHMatters) P100910.AU.2
8/20 
CII 
GtE 103
102
Etrolizumab Placebo 
1570.1% 1515.0% 
_0 
103io - ORNo.10
102,' 102, 
105 - 2.8% 105- 17.3% 
0 N0 
00 
102 12Wi 4 i ~ 12 o  o  o 
0 -M0 
102 103 1o4  1o5 102 1o 3  1o4  105 
105_ 5.~7% 0_17
Patent AU-2021202140-A1 (AU)
Title: Grouped feature map quantisation
Inventor: ROSEWARNE CHRISTOPHER JAMES
IPC: H04N19/124
Filed: 2021-04-07
Abstract: GROUPED FEATURE MAP QUANTISATION 
A method of decoding feature maps from encoded data. A parameter related to quantisation is 
determined. According to the parameter, inverse quantisation is performed for samples 
decoded from the encoded data to decode the feature maps. For at least a part of the samples 
decoded from the encoded data, one parameter is shared by a group of samples corresponding 
to a plurality of feature maps.  
27237223v1
1/19 
100 
Source device IDestination device 
110 I 140 
I Task result 
Video source I Display device bufferI 
112 1 16015 
CNN backbone i CNN head 
114 I I150 
L II 159 
-115 I 14 I 
Feature map I Feature unpacker I 
quant and packer iand inverse quant 
116 I 148 
117 iI147I 
118 125 I161551 
119 I 45) 
Video encoder I Video decoder I 
120 I144 
121 -- Storage I 
Transmitter II Receiver 
122 142 
-I 130 - -- -- -- -- -- ---
Fig.I1